ImmunityBio (IBRX) Current Assets (2014 - 2026)
ImmunityBio (IBRX) reported Current Assets of $438.98 million for Q2 2026, up 110.9% from $208.13 million a year earlier but down 3.1% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, ImmunityBio posted Current Assets of $314.88 million, up 70.6% from FY2024.
- Current Assets has a five-year compound annual growth rate of 23.0% (FY2020 to FY2025).
- By year, Current Assets came in at $184.59 million in FY2024 (-37.2%), $294.08 million in FY2023 (+109.2%), $140.58 million in FY2022 (-58.0%) and $334.35 million in FY2021 (+199.3%).
- Five-year quarterly Current Assets spans a low of $66.83 million in Q2 2023 and a high of $452.95 million in Q1 2026.
- Year over year, Current Assets has now increased in each of the last four quarters, with growth averaging 59.8% over the last eight quarters.
- The high point for year-over-year Current Assets in five years was Q1 2026 (growth of 314.9%); the low point was Q4 2022 (a decline of 58.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $452.95 million (Q1 2026), $314.88 million (Q4 2025) and $329.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | ImmunityBio | 8.97 Bn | 7.74 Bn | 50.94 Mn | 438.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 438.98 Mn |
| Mar 31, 2026 | 452.95 Mn |
| Dec 31, 2025 | 314.88 Mn |
| Sep 30, 2025 | 329.50 Mn |
| Jun 30, 2025 | 208.13 Mn |
| Mar 31, 2025 | 109.16 Mn |
| Dec 31, 2024 | 184.59 Mn |
| Sep 30, 2024 | 163.15 Mn |
| Jun 30, 2024 | 242.83 Mn |
| Mar 31, 2024 | 195.72 Mn |
| Dec 31, 2023 | 294.08 Mn |
| Sep 30, 2023 | 215.08 Mn |
| Jun 30, 2023 | 66.83 Mn |
| Mar 31, 2023 | 113.49 Mn |
| Dec 31, 2022 | 140.58 Mn |
| Sep 30, 2022 | 143.09 Mn |
| Jun 30, 2022 | 114.99 Mn |
| Mar 31, 2022 | 212.34 Mn |
| Dec 31, 2021 | 334.35 Mn |
| Sep 30, 2021 | 94.45 Mn |
API Access
ImmunityBio Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();